Paper Details

  1. Home
  2. Paper Details

Atenolol in the treatment of angina pectoris.

Author: DedichenJ, ErikssenJ, OsvikK

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Atenolol, a beta-blocker, significantly reduced heart rate and blood pressure in patients with stable angina pectoris. 15 out of 19 patients experienced subjective improvement on atenolol. The study found a mean increase of 44% in bicycle exercise performance on atenolol, compared to placebo. No serious side effects were reported.
Paper Details　
Original Abstract of the Article :
Nineteen men, aged 41-64 years, with stable angina pectoris have completed a random double-blind study of atenolol, 50 mg b.i.d., atenolol, 100 mg b.i.d., and placebo. Fifteen patients had subjective improvement on atenolol, two were unchanged and two felt worse (because of asthenia/leg fatigue). No...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.0954-6820.1977.tb15751.x

データ提供：米国国立医学図書館（NLM）

Atenolol: A Steady Heartbeat in the Desert

This study, published in 1978, explores the effects of atenolol, a beta-blocker used to manage angina pectoris, a condition characterized by chest pain caused by reduced blood flow to the heart. The researchers studied the effects of atenolol in 19 men with stable angina, comparing its effectiveness to a placebo. The findings, like a well-worn camel trail, provide insights into the benefits and effectiveness of this medication.

Atenolol: A Heartbeat of Relief

The study found that atenolol, like a cool oasis in the desert heat, significantly reduced heart rate at rest and during exercise, improving exercise tolerance and reducing chest pain in patients with angina. These findings underscore the potential of atenolol to provide relief and improve quality of life for individuals struggling with this condition.

Navigating the Desert of Angina

It is important to remember that every camel's heart beats differently. The right treatment for you will depend on your individual needs and health history. Always consult with a healthcare professional to determine the most suitable treatment for your angina.

Dr. Camel's Conclusion

This study, like a caravan traveling through a challenging landscape, provides valuable insights into the effectiveness of atenolol in managing angina pectoris. The research highlights the potential of atenolol to offer a safe and effective treatment option for this condition, offering a beacon of hope for those seeking relief.
Date :
  1. Date Completed 1977-08-25
  2. Date Revised 2019-08-12
Further Info :

Pubmed ID

17996

DOI: Digital Object Identifier

10.1111/j.0954-6820.1977.tb15751.x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.